The prevalence of polycystic ovarian syndrome in Chinese women: a meta-analysis
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
BACKGROUND: To estimate the prevalence of polycystic ovarian syndrome (PCOS) in Chinese women comprehensively and to provide references to prevent PCOS. METHODS: China National Knowledge Infrastructure, Wanfang Data, China Science and Technology Journal Database, Chinese Biology Medicine, PubMed, Embase, Web of Science, CENTRAL, CINAHL were searched to collect studies on the prevalence of PCOS from database inception from March 31, 2020. Two reviewers independently screened literature according to the inclusion and exclusion criteria of the articles, extracted data, and tested the risk of bias of the included studies. Then Stata 15.1 software performed a meta-analysis. Begg's and Egger's method were used to assess the risk of publication bias. RESULTS: A total of 69 studies were involved, including 154,599 participants, 12,845 patients developed PCOS. The prevalence of PCOS was 10.01% (95% CI: 8.31% to 11.89%). Subgroup analysis showed that the prevalence of PCOS in different regions was as follows: 13.35% in the west, 7.82% in the east, 14.24% in the middle, and 8.68% in the north-east. Subgroup analysis by occupation/status: the prevalence rates of workers, students, medical staff, cadres, farmers, staff, and service staff were respectively 10.37%, 16.37%, 13.97%, 6.05%, 7.05%, 8.05%, 9.05%. For individuals aged 10 to 20, between 21 and 30, 31 to 40, and above 40, the prevalence rate was 10.26%, 17.23%, 9.13%, 2.22%, respectively. The prevalence rates of PCOS 1995 to 2000 were 21.04%, from 2001 to 2005, was 5.86%, from 2006 to 2010 was 10.78%, from 2011 to 2015 was 11.44%, and during 2016 to 2020 was 5.79%. Hospital-based community-based and school-based studies were 13.41%, 5.95%, 3.01%. According to the subgroup analysis of the surveyed population, the prevalence of PCOS in the general population and infertility patients were 6.05% and 13.69%, respectively. CONCLUSIONS: The prevalence rate of PCOS is high in Chinese women, and the prevalence of PCOS varies with different regions, occupation/identity, age, time of publication, diagnostic criteria, survey time, and prevalence of the surveyed population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743 · cited 1×
“Pollutants, including smoke, lead, pesticides, and mercury, may damage women’s reproductive health and may trigger or aggravate PCOS and its related symptoms (90).”
BackgroundTeede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565 · cited 2×
“The main manifestations are menstrual disorders and reproductive dysfunction (2-4), one of the leading causes of females in anovulatory infertility (5,6).”
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488 · cited 1×
“(II) Students often have lousy living habits, including reversed work and rest and irregular eating and less exercise and exercise, and these are all predisposing factors for PCOS (92).”
BackgroundPolycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
Patel, S. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.04.008 · Cited by 605 · cited 1×
“In recent years, the incidence of PCOS has all increased (84), and with the improvement of diagnostic methods and the level of diagnosis and treatment, its prevalence may change accordingly.”
BackgroundGenetic, hormonal and metabolic aspects of PCOS: an update
De Leo, V., Musacchio, M. C., Cappelli, V., Massaro, M. G., Morgante, G., & Petraglia, F. (2016) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-016-0173-x · Cited by 484 · cited 1×
“Most scholars believe it may be related to the abnormal regulation function of the hypothalamicpituitary-ovarian axis, hyperinsulinemia and insulin resistance, abnormal adrenal endocrine function, heredity, and other aspects (8,9).”
BackgroundDing, T., Hardiman, P. J., Petersen, I., Wang, F.-F., Qu, F., & Baio, G. (2017) · Oncotarget · doi:10.18632/oncotarget.19180 · Cited by 336 · cited 1×
“However, the prevalence of PCOS in this study was lower than that in Middle Eastern women (16%) (85), which may be related to race, region, economic and cultural level, and the improvement of PCOS knowledge and diagnosis.”
BackgroundPuurunen, J., Piltonen, T., Morin-Papunen, L., Perheentupa, A., Järvelä, I., Ruokonen, A., & Tapanainen, J. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0039 · Cited by 108 · cited 2×
“Even after menopause, women with PCOS still often have higher levels of androgen and insulin resistance (3,9).”
Background
Cited by
Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., & Piltonen, T. T. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00511-3 · Cited by 495
Meng, Y., Zhao, T., Zhang, R., Zhu, X., Ma, C., & Shi, Q. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1514250 · Cited by 43
Zhou, J., Zuo, W., Tan, Y., Wang, X., Zhu, M., & Zhang, H. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01130-4 · Cited by 16
Metadata
- Authors
- Wu, Q., Gao, J., Bai, D., Yang, Z., & Liao, Q.
- Venue
- Annals of Palliative Medicine
- Publisher
- AME Publishing Company
- Published
- 2021-01
- Volume
- 10
- Issue
- 1
- Pages
- 74-87
- ISSN
- 2224-5820 (ISSN-L)
- 2224-5839
- OpenAlex
- W3124912776
- Cited by
- 67
- References
- 7
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.